Drug Information

Drug General Information
Drug ID
D0S6GJ
Former ID
DIB014501
Drug Name
KC-764
Synonyms
(2-Methylpyrazolo[1,5-a]pyridin-3-yl)(1,4,5,6-tetrahydro-3-pyridyl)methanone; 2-Methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine; 2-Methyl-3-(1,4,5,6-tetrahydropyridin-3-ylcarbonyl)pyrazolo[1,5-a]pyridine; 94457-09-7
Drug Type
Small molecular drug
Indication Platelet aggregatory [ICD10:D69.1] Discontinued in Phase 3 [544800]
Formula
C14H15N3O
Canonical SMILES
CC1=NN2C=CC=CC2=C1C(=O)C3=CNCCC3
InChI
1S/C14H15N3O/c1-10-13(12-6-2-3-8-17(12)16-10)14(18)11-5-4-7-15-9-11/h2-3,6,8-9,15H,4-5,7H2,1H3
InChIKey
SLMUMPSLUWOXAO-UHFFFAOYSA-N
CAS Number
CAS 94457-09-7
PubChem Compound ID
146826
PubChem Substance ID
10249406, 12013507, 15196449, 46223996, 57346451, 77587832, 104415016, 126440773, 135103488, 135953410, 140727662, 162755499, 224867595, 226486579
Target and Pathway
Target(s) Cyclooxygenase Target Info Modulator [527720], [551871]
References
Ref 544800Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001148)
Ref 527720Clinical and preclinical pharmacology of KC-764, a novel antiplatelet agent. Nihon Rinsho. 1992 Feb;50(2):379-84.
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.